Fuster V - Search Results

1

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

Patrono C, Coller B, Dalen JE, Fuster V, Gent M, Harker LA, Hirsh J, Roth G. Patrono C, et al. Among authors: fuster v. Chest. 1998 Nov;114(5 Suppl):470S-488S. doi: 10.1378/chest.114.5_supplement.470s. Chest. 1998. PMID: 9822058 Review. No abstract available.

2

Platelet-active drugs : the relationships among dose, effectiveness, and side effects.

Patrono C, Coller B, Dalen JE, FitzGerald GA, Fuster V, Gent M, Hirsh J, Roth G. Patrono C, et al. Among authors: fuster v. Chest. 2001 Jan;119(1 Suppl):39S-63S. doi: 10.1378/chest.119.1_suppl.39s. Chest. 2001. PMID: 11157642 Review. No abstract available.

3

Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.

Hirsh J, Dalen JE, Fuster V, Harker LB, Salzman EW. Hirsh J, et al. Among authors: fuster v. Chest. 1992 Oct;102(4 Suppl):327S-336S. Chest. 1992. PMID: 1395819 Review. No abstract available.

4

Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.

Hirsh J, Salzman EW, Harker L, Fuster V, Dalen JE, Cairns JA, Collins R. Hirsh J, et al. Among authors: fuster v. Chest. 1989 Feb;95(2 Suppl):12S-18S. Chest. 1989. PMID: 2644095 Review. No abstract available.

5

Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects.

Hirsh J, Dalen JE, Fuster V, Harker LB, Patrono C, Roth G. Hirsh J, et al. Among authors: fuster v. Chest. 1995 Oct;108(4 Suppl):247S-257S. doi: 10.1378/chest.108.4_supplement.247s. Chest. 1995. PMID: 7555180 Review. No abstract available.

6

Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness.

Hirsh J, Fuster V, Salzman E. Hirsh J, et al. Among authors: fuster v. Chest. 1986 Feb;89(2 Suppl):4S-10S. doi: 10.1378/chest.89.2_supplement.4s. Chest. 1986. PMID: 3510829 Review. No abstract available.

7

Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.

Hirsh J, Fuster V. Hirsh J, et al. Among authors: fuster v. Circulation. 1994 Mar;89(3):1449-68. doi: 10.1161/01.cir.89.3.1449. Circulation. 1994. PMID: 8124829 No abstract available.

8

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

Hirsh J, Fuster V. Hirsh J, et al. Among authors: fuster v. Circulation. 1994 Mar;89(3):1469-80. doi: 10.1161/01.cir.89.3.1469. Circulation. 1994. PMID: 8124830 No abstract available.

9

Antithrombotic effects of abciximab.

Hayes R, Chesebro JH, Fuster V, Dangas G, Fallon JT, Sharma SK, Coller BS, Badimon L, Marmur JD, Badimon JJ. Hayes R, et al. Among authors: fuster v. Am J Cardiol. 2000 May 15;85(10):1167-72. doi: 10.1016/s0002-9149(00)00722-0. Am J Cardiol. 2000. PMID: 10801995 Clinical Trial.

10

Mechanism of action and pharmacology of unfractionated heparin.

Hirsh J, Anand SS, Halperin JL, Fuster V. Hirsh J, et al. Among authors: fuster v. Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1094-6. doi: 10.1161/hq0701.093686. Arterioscler Thromb Vasc Biol. 2001. PMID: 11451734 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,571 results

Search Page